Federal officials say the FDA is reviewing reports of possible deaths in adults and children following COVID-19 vaccination.
Federal regulators have begun a safety review of 2 RSV medicines used to protect infants, even though no safety problems have been reported.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback